Treatment Overview
The DME Intravitreal Steroid Injection in Korea is a minimally invasive therapy designed to treat diabetic macular edema (DME) by reducing inflammation and retinal swelling. Steroid injections deliver anti-inflammatory medication directly into the vitreous cavity, targeting the macula to decrease vascular leakage and improve visual function.
Korea is recognized globally for its advanced intravitreal steroid programs, integrating:
- High-precision intravitreal injection techniques
- Steroids such as triamcinolone acetonide or dexamethasone implants (Ozurdex®)
- OCT-guided planning to identify areas of macular thickening
- Combined therapy protocols with anti-VEGF agents or laser photocoagulation
- AI-assisted monitoring of macular edema resolution
- Post-injection safety protocols to prevent complications
This program provides effective stabilization of vision in DME patients, especially for those resistant to anti-VEGF therapy.
Purpose & Benefits
Purpose
- Reduce macular edema in diabetic patients
- Improve or stabilize visual acuity in chronic DME
- Minimize inflammation-induced retinal damage
- Serve as an alternative for patients not responding to anti-VEGF therapy
- Complement laser therapy in combination protocols
- Prevent progression to severe vision loss
Benefits
- Minimally invasive outpatient procedure
- Direct delivery to the vitreous for rapid effect
- Can provide longer-lasting edema control compared to anti-VEGF in certain patients
- Safe and effective when administered by experienced Korean specialists
- Can be combined with OCT imaging for precise monitoring
- Quick procedure with rapid visual recovery for most patients
- Reduces central retinal thickness and improves macular structure
Ideal Candidates
The DME Intravitreal Steroid Injection Program in Korea is ideal for:
- Patients with chronic DME not responding to anti-VEGF therapy
- Individuals with pseudophakic eyes (post-cataract surgery)
- High-risk diabetic patients with persistent macular edema
- Patients with contraindications to frequent anti-VEGF injections
- Individuals requiring combination therapy with grid laser photocoagulation
- Patients needing structural stabilization of the macula
Possible Risks & Complications
Intravitreal steroid injections are generally safe, but potential risks include:
Common/Moderate Risks:
- Temporary blurred vision or mild eye discomfort
- Mild increase in intraocular pressure (IOP)
- Eye redness or irritation
- Floaters in the vision for a short period
Rare/Serious Risks:
- Infection inside the eye (endophthalmitis)
- Significant IOP elevation requiring medication or surgery
- Cataract progression (in phakic eyes)
- Retinal detachment (extremely rare)
Korean specialists minimize risks with:
- Strict aseptic injection protocols
- Pre- and post-injection IOP monitoring
- OCT imaging to guide injection and monitor response
- Regular follow-up and early intervention for complications
Related Treatment Techniques
- Anti-VEGF Therapy
Used in combination for synergistic effect in persistent DME. - Grid Laser Photocoagulation
Stabilizes macular structure alongside steroid therapy. - OCT-Guided Monitoring
Assesses macular thickness and edema resolution post-injection. - Combination Therapy
Anti-VEGF + steroid + laser tailored for resistant DME cases. - Vitrectomy Surgery
Considered for tractional or complex DME cases unresponsive to injections.
Treatment Process in Korea
Step 1 – Baseline Imaging and Assessment
- OCT and fundus photography to determine macular thickness and edema
- Medical history and intraocular pressure measurement
Step 2 – Injection Planning
- Selection of steroid type (triamcinolone or dexamethasone implant)
- Determination of dosage and treatment schedule
Step 3 – Intravitreal Injection
- Topical anesthesia applied
- Steroid injected into the vitreous cavity under sterile conditions
- Post-injection fundus and IOP check
Step 4 – Post-Injection Monitoring
- OCT and IOP follow-up at regular intervals
- Visual acuity assessment and retinal evaluation
Step 5 – Maintenance & Repeat Injections
- Repeat injections scheduled based on edema recurrence and treatment response
- Combination with anti-VEGF or laser therapy if indicated
Program Duration: 15–30 minutes
Setting: Advanced retinal clinic or hospital
Recovery & After-Care
After-Care Guidelines
- Avoid rubbing or pressing the eye
- Monitor for pain, redness, or sudden vision changes
- Use prescribed anti-inflammatory eye drops as directed
- Attend scheduled OCT follow-up visits for safety and efficacy
Recovery Timeline
- Immediate: Mild blurred vision or eye irritation
- 1–2 Weeks: Inflammation typically resolves, edema reduction visible on OCT
- 1–6 Months: Macular thickness stabilizes; repeat injection if necessary
- Long-Term: Periodic monitoring ensures long-term retinal health
Results & Longevity
Expected Results
- Reduction of central macular thickness
- Stabilization or modest improvement in visual acuity
- Improved structural integrity of the macula
- Complements other DME therapies for resistant cases
- Prevention of further vision loss
Longevity
- Effects may last 3–6 months depending on steroid type
- Repeat injections may be required for chronic DME
- Combination therapy prolongs treatment benefits
- OCT monitoring ensures timely intervention for recurrence
Why Korea Is a Top Destination
- Experienced retinal specialists with expertise in intravitreal injections
- Advanced OCT and fundus imaging for precise planning and follow-up
- Integration with laser therapy and anti-VEGF treatments
- Strict aseptic protocols to minimize infection risk
- Personalized treatment plans based on macular imaging and patient response
- Efficient outpatient procedure with rapid recovery
Unique Korean Innovations
- OCT-guided intravitreal steroid planning
- AI-assisted monitoring of macular edema reduction
- Combination therapy protocols with laser and anti-VEGF
- Longitudinal imaging dashboards for serial evaluation
- Precise dosing and implant placement techniques
These innovations make Korea’s
DME Intravitreal Steroid Injection Program
one of the most advanced and effective treatments for chronic diabetic macular edema worldwide.
Cost Range (Indicative Estimate)
| Program Package | Price (KRW) | Approx. USD | Inclusions |
|---|---|---|---|
| Single Triamcinolone Injection | ₩300,000 – ₩500,000 | ~$230 – $380 | Baseline OCT + injection + follow-up |
| Dexamethasone Implant (Ozurdex®) | ₩1,200,000 – ₩1,800,000 | ~$920 – $1,380 | OCT-guided implant + follow-up monitoring |
| Combination DME Therapy | ₩1,500,000 – ₩2,500,000+ | ~$1,150 – $1,900+ | Steroid + anti-VEGF ± laser + OCT follow-up |
Popular Clinics in Korea
- B&VIIT Eye Center (Seoul)
- Dream Eye Center (Seoul)
- BGN Eye Clinic (Seoul & Busan)
- Glory Seoul Eye Clinic
- Kim’s Eye Hospital (Seoul)
- NUNE Eye Hospital (Daegu)
- Seoul National University Hospital Retina Center
- Gangnam Severance Hospital Ophthalmology
